RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties

← Drug Reference

Droperidol

Reduction of nausea and vomiting associated with surgical and diagnostic procedures.

Boxed warning

  • WARNING Cases of QT prolongation and/or torsade de pointes have been reported in patients receiving droperidol at doses at or below recommended doses. Some cases have occurred in patients with no known risk factors for QT prolongation and some cases have been fatal. Due to its potential for serious proarrhythmic effects and death, droperidol should be reserved for use in the treatment of patients who fail to show an acceptable response to other adequate treatments, either because of insufficient effectiveness or ... (see full label)

Indications

  • Reduction of nausea and vomiting associated with surgical and diagnostic procedures.

Adult dosing

  • maintenance nausea vomiting: dose: 1.25; unit: mg; route: IV; interval: additional doses as needed; fixed: true; titrationTarget: Titrate to effect. desired effect; labelExcerpt: Additional 1.25 mg doses of droperidol may be administered to achieve the desired effect.

Pediatric dosing

  • Consult pharmacy/current label

Renal adjustment

  • Consult pharmacy/current label

Hepatic adjustment

  • Consult pharmacy/current label

Contraindications

  • Known or suspected QT prolongation
  • Congenital long QT syndrome
  • Known hypersensitivity to droperidol

Clinical pearls

  • Maximum, not a starting dose (label): maximum recommended initial dose 2.5 mg IM or slow IV
  • Maximum, not a starting dose (label): children 2-12 y maximum recommended initial dose 0.1 mg/kg
  • Requires 12-lead ECG prior to administration; contraindicated if QTc >440 msec (males) or >450 msec (females).
  • Perform ECG monitoring for 2-3 hours after completion of treatment.
  • Reserved for patients who fail to respond to other adequate antiemetic treatments.
  • Potentiates CNS depressants; administer with extreme caution in patients at risk for prolonged QT syndrome.

Source and review

  • DailyMed label (droperidol), Set ID 147e033d-d997-4ef6-8bb5-a9ba372590b2, effective 2023-03-20. Last reviewed: 2026-11-11